Risk factors for osteonecrosis of the femoral head in brain tumor patients receiving corticosteroid after surgery.
Seung-Jae LimIngwon YeoChan-Woo ParkHyeon LeeYoun-Soo ParkJung-Il LeePublished in: PloS one (2020)
This study demonstrated that the prevalence of ONFH after surgical resection of primary brain tumor was 0.68%. Diabetes was an independent risk factor for developing ONFH, whereas corticosteroid dose was not. Routine screening for brain tumor-associated ONFH is not recommended; however, a high index of clinical suspicion in these patients at risk may allow for early intervention and preservation of the joints.
Keyphrases
- end stage renal disease
- randomized controlled trial
- ejection fraction
- type diabetes
- newly diagnosed
- cardiovascular disease
- chronic kidney disease
- white matter
- clinical practice
- adipose tissue
- resting state
- patient reported outcomes
- metabolic syndrome
- skeletal muscle
- functional connectivity
- blood brain barrier
- weight loss